Staging of immuno-virological dynamics during acute HIV infection in a Belgian prospective cohort study by De Clercq, Jozefien, De Scheerder, Marie-Angélique, Vanherrewege, Sophie, Caluwé, Els, Moreels, Nathalie, Delooze, Danny, Dhondt, Annemieke, Coppens, Marc, Vandecasteele, Stefaan J., Allard, Sabine D., Necsoi, Coca, De Wit, Stéphane, Gerlo, Sarah, Vandekerckhove, Linos

Get full text

Incidence of Hypertension and Blood Pressure Changes in Persons With Human Immunodeficiency Virus at High Risk for Cardiovascular Disease Switching From Boosted Protease Inhibitors... by Sempere, Abiu, Assoumou, Lambert, González-Cordón, Ana, Waters, Laura, Rusconi, Stefano, Domingo, Pere, Gompels, Mark, de Wit, Stephane, Raffi, François, Stephan, Christoph, Masiá, Mar, Rockstroh, Jürgen, Katlama, Christine, Behrens, Georg M N, Moyle, Graeme, Johnson, Margaret, Fox, Julie, Stellbrink, Hans-Jürgen, Guaraldi, Giovanni, Florence, Eric, Esser, Stefan, Gatell, José, Pozniak, Anton, Martínez, Esteban

Get full text

Limited Weight Impact After Switching From Boosted Protease Inhibitors to Dolutegravir in Persons With Human Immunodeficiency Virus With High Cardiovascular Risk: A Post Hoc Analys... by Waters, Laura, Assoumou, Lambert, González-Cordón, Ana, Rusconi, Stefano, Domingo, Pere, Gompels, Mark, de Wit, Stephane, Raffi, François, Stephan, Christoph, Masiá, Mar, Rockstroh, Jürgen, Katlama, Christine, Behrens, Georg M N, Moyle, Graeme, Johnson, Margaret, Fox, Julie, Stellbrink, Hans-Jürgen, Guaraldi, Giovanni, Florence, Eric, Esser, Stefan, Gatell, José M, Pozniak, Anton, Martínez, Esteban

Get full text

Immediate Versus Deferred Switching From a Boosted Protease Inhibitor-based Regimen to a Dolutegravir-based Regimen in Virologically Suppressed Patients With High Cardiovascular Ri... by Gatell, José M, Assoumou, Lambert, Moyle, Graeme, Waters, Laura, Johnson, Margaret, Domingo, Pere, Fox, Julie, Martinez, Esteban, Stellbrink, Hans-Jürgen, Guaraldi, Giovanni, Masia, Mar, Gompels, Mark, De Wit, Stephane, Florence, Eric, Esser, Stefan, Raffi, François, Stephan, Christoph, Rockstroh, Juergen, Giacomelli, Andrea, Vera, Jaime, Bernardino, José Ignacio, Winston, Alan, Saumoy, Maria, Gras, Julien, Katlama, Christine, Pozniak, Anton L

Get full text

Switching from boosted PIs to dolutegravir decreases soluble CD14 and adiponectin in high cardiovascular risk people living with HIV by González-Cordón, Ana, Assoumou, Lambert, Moyle, Graeme, Waters, Laura, Johnson, Margaret, Domingo, Pere, Fox, Julie, Stellbrink, Hans-Jürgen, Guaraldi, Giovanni, Masiá, Mar, Gompels, Mark, De Wit, Stephane, Florence, Eric, Esser, Stefan, Raffi, François, Behrens, Georg, Pozniak, Anton, Gatell, José M., Martínez, Esteban

Get full text

Long-term effects on subclinical cardiovascular disease of switching from boosted protease inhibitors to dolutegravir by González-Cordón, Ana, Assoumou, Lambert, Moyle, Graeme, Waters, Laura, Johnson, Margaret, Domingo, Pere, Fox, Julie, Stellbrink, Hans-Jürgen, Guaraldi, Giovanni, Masiá, Mar, Gompels, Mark, De Wit, Stephane, Florence, Eric, Esser, Stefan, Raffi, François, Behrens, Georg, Pozniak, Anton, Gatell, Jose M, Martínez, Esteban

Get full text

Switching from boosted PIs to dolutegravir in HIV-infected patients with high cardiovascular risk: 48 week effects on subclinical cardiovascular disease by Gonzalez-Cordon, Ana, Assoumou, Lambert, Camafort, Miguel, Domenech, Monica, Guaraldi, Giovanni, Domingo, Pere, Rusconi, Stefano, Raffi, François, Katlama, Christine, Masia, Mar, Bernardino, Jose I, Saumoy, Maria, Pozniak, Anton, Gatell, Jose M, Martinez, Esteban

Get full text

Incidence of hypertension and blood pressure changes in persons with HIV at high risk for cardiovascular disease switching from boosted protease inhibitors to dolutegravir: a post-... by Sempere, Abiu, Assoumou, Lambert, González-Cordón, Ana, Waters, Laura, Rusconi, Stefano, Domingo, Pere, Gompels, Mark, de Wit, Stephane, Raffi, François, Stephan, Christoph, Masiá, Mar, Rockstroh, Jürgen, Katlama, Christine, Behrens, Georg M N, Moyle, Graeme, Johnson, Margaret, Fox, Julie, Stellbrink, Hans-Jürgen, Guaraldi, Giovanni, Florence, Eric, Esser, Stefan, Gatell, José, Pozniak, Anton, Martínez, Esteban

Get full text

In depth analysis of the HIV reservoir confirms effectiveness and safety of DTG/3TC in a phase 4 randomized controlled switch trial (RUMBA) by De Scheerder, Marie-Angélique, Degroote, Sophie, Delporte, Mareva, Kiselinova, Maja, Trypsteen, Wim, Vincke, Lara, De Smet, Evelien, Van Den Eeckhout, Bram, Schrooyen, Loïc, Verschoore, Maxime, Muccini, Camilla, Vanherrewege, Sophie, Caluwe, Els, De Buyser, Stefanie, Gerlo, Sarah, Blomme, Evy, Vandekerckhove, Linos

Get full text

In-depth Analysis of the HIV Reservoir Confirms Effectiveness and Safety of Dolutegravir/Lamivudine in a Phase 4 Randomized Controlled Switch Trial (RUMBA) by De Scheerder, Marie-Angélique, Degroote, Sophie, Delporte, Mareva, Kiselinova, Maja, Trypsteen, Wim, Vincke, Lara, De Smet, Evelien, Van Den Eeckhout, Bram, Schrooyen, Loïc, Verschoore, Maxime, Muccini, Camilla, Vanherrewege, Sophie, Caluwe, Els, De Buyser, Stefanie, Gerlo, Sarah, Blomme, Evy, Vandekerckhove, Linos

Get full text

Long-Term Follow-Up of Children with Heart Block Born from Mothers with Systemic Lupus Erythematosus: A Retrospective Study from the Database Pediatric and Congenital Heart Disease... by DE CALUWÉ, EVA, VAN DE BRUAENE, ALEXANDER, WILLEMS, RIK, TROOST, ELS, GEWILLIG, MARC, REGA, FILIP, BUDTS, WERNER

Get full text